N
NeuronUP
Platform designed to support professionals involved in cognitive rehabilitation and stimulation processes
About NeuronUP
NeuronUP is a web-based platform specializing in cognitive rehabilitation tools designed for professionals such as occupational therapists, speech therapists, and other neurorehabilitation experts. The company operates in the healthcare and neuropsychology market, focusing on providing resources for the treatment of conditions like ADHD, Alzheimer's, stroke, acquired brain injury, and various neurodegenerative and neurodevelopmental disorders. NeuronUP's business model revolves around subscription-based access to its extensive library of cognitive exercises and activities, which are tailored to meet the specific needs of each patient. By offering customizable and intensive brain training programs, NeuronUP aims to save time for professionals while ensuring high levels of patient engagement and therapeutic effectiveness. The platform's activities are designed to improve memory, attention, social cognition, language, and executive functions, making it a comprehensive tool for cognitive rehabilitation.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2011
- Headquarters
- Logroño, Spain
- Employees
- 113
- Open positions
- 4
- Dealroom signal
- 76.8/100
- Industry
- Sports
- Sub-industry
- Sport Platform & Application
- Sector
- Sports, Tea, Health Care, Intellectual Property, Health, Neurology
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Jun 2024 | $11M | $44M | Moira Capital Partners | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for NeuronUP is 420K monthly website visits, up 13.5% over the last three months. NeuronUP's team grew 7.6% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
SipNoseSipNose focuses on nose-to-brain medical applications and is developing a nasal delivery platform for local, systemic, and central nervous system indications |
Singapore, Singapore | Operational | 2 | — | — |
MEDtubeSocial eLearning platform for Health Professionals and Med Students |
Warsaw, Poland | Operational | |||
CovidienGlobal Healthcare Products Leader |
Dublin, Ireland | Acquired | |||
AQUAECAAQUAECA: disinfection and water treatment |
L'Hospitalet de Llobregat, Spain | Operational | |||
SpectAquilarImage Guided Interventional Augmented Reality Procedures |
Rehovot, Israel | Operational | |||
CompetitorCompetitor specializes in the R&D, production, and sales of sports nutrition foods, technologies, and professional services |
China | Operational | |||
| Ashkelon, Israel | Operational | ||||
MemoradoBuilding the globally leading cognitive enhancement product |
Germany | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Moira Capital Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about NeuronUP on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NeuronUP’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






